Australia markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.0400+0.0400 (+1.00%)
At close: 04:00PM EDT
3.9100 -0.13 (-3.22%)
After hours: 06:49PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.61-0.68-2.76-2.92
Low estimate-0.63-0.75-3.03-3.14
High estimate-0.57-0.62-2.5-2.5
Year ago EPS-0.43-0.34-1.63-2.76
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3322
Avg. EstimateN/AN/AN/A42.95M
Low estimateN/AN/AN/A38M
High estimateN/AN/AN/A47.9M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.48-0.47-0.48-0.5
Actual EPS-0.43-0.34-0.4-0.47
Difference0.050.130.080.03
Surprise %10.40%27.70%16.70%6.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.61-0.68-2.76-2.92
7 days ago-0.61-0.68-2.76-2.92
30 days ago-0.61-0.64-2.820.1
60 days ago-0.57-0.62-2.820.13
90 days ago-0.57-0.62-2.820.13
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAVIRIndustrySector(s)S&P 500
Current qtr.-41.90%N/AN/AN/A
Next qtr.-100.00%N/AN/AN/A
Current year-69.30%N/AN/AN/A
Next year-5.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A